U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416566) titled 'Low-Dose Enoxaparin in Psoriasis' on May 10.

Brief Summary: Rationale:

* Psoriasis is a chronic immune-mediated inflammatory skin disorder where T cells play a fundamental role in its pathogenesis.

* Low molecular weight heparin has been reported to exert immunomodulatory effect at small doses through inhibition of T cells heparinase enzyme.

* Low molecular weight heparin may have promising results for treatment of psoriasis.

Research question:

* Can low molecular weight heparin be used safely for treatment of psoriasis with good outcome?

* Is enoxaparin inhibitory effect on T cell heparinase enzyme responsible for its benefici...